US President Trump has signed an executive order designed to lower the cost of prescription drug prices, which includes a win for manufacturers of small molecule drugs. The order comes one day after the Trump administration instituted a national security report into the pharmaceutical industry, which is… Read More
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved the first generic raltegravir drug to treat adult and paediatric HIV patients who weigh at least 40kg. HIV produces an enzyme called HIV integrase which enables multiplication of the virus in cells within the body. Read More
Claire D’Abreu-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost. This will continue to be the case going forward,… Read More
By Dr Natalia Dadivanyan, Segment Marketing Manager, Malvern Panalytical Small molecules can face big challenges Despite the emergence of, and excitement around, advanced therapeutic modalities, traditional small molecule pharmaceuticals still occupy a significant and steadily growing share of the market. A recent report indicated… Read More
As the world’s largest generic producer how far advanced is India’s drug discovery push and where does it stand on the global stage? Lu Rahman explores. India has become a key player in the global pharmaceutical sector. The value of its part in this industry is expected to reach $120… Read More
